Biotech stocks live and die on access to capital, so the Federal Reserve’s signal that interest rates may pause for now gives this high risk corner of the market some breathing room. Cheaper money can make it easier to fund drug pipelines and clinical trials, which matters if you are hunting for the next breakthrough. This article highlights three financially grounded biotech stocks that could potentially benefit from this environment. The three biotech stocks in focus below are just a small...

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

Find the latest Arrowhead Pharmaceuticals, Inc. (ARWR) stock quote, history, news and other vital information to help you with your stock trading and investing.

Arrowhead Pharmaceuticals, Inc. on Wednesday shared interim data from an ongoing Phase 1/2a clinical trial for ARO-MAPT, an investigational RNA interference therapy targeting Alzheimer’s disease and o...

Vea los precios de cotización de acciones de Arrowhead Pharmaceuticals, Inc. ARWR, información financiera, pronósticos en tiempo real y noticias de la compañía de CNN.

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

Arrowhead’s first tau-lowering data in humans bring brain shuttles a step closer to opening the CNS to systemically administered RNAi therapies. But...

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

Arrowhead Pharmaceuticals (NASDAQ:ARWR) presented interim Phase I/II data for ARO-MAPT, an investigational small interfering RNA therapy designed to reduce tau protein expression in the central nervous system, alongside initial clinical results for its TRiM CNS delivery platform. The company said t